Pheburane

sodium phenylbutyrate · Eurocept International B. V.
AUTHORISED IN THE EU

What Pheburane is used for

Treatment of chronic management of urea-cycle disorders.

Approved use, as published by the European Medicines Agency.

Key facts

Brand
Pheburane
Active substance
sodium phenylbutyrate
Disease area
Carbamoyl-Phosphate Synthase I Deficiency Disease
Medicine group
Various alimentary tract and metabolism products
ATC code
A16AX03
Marketing authorisation holder
Eurocept International B. V.
Authorised in the EU since
2013

Official information

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is Pheburane used for?

Treatment of chronic management of urea-cycle disorders.

What is the active substance in Pheburane?

Pheburane contains sodium phenylbutyrate.

Who makes Pheburane?

The EU marketing authorisation holder is Eurocept International B. V..

Source: European Medicines Agency medicines data (ema.europa.eu), reproduced with acknowledgement of the source. Page made 5 November 2026 by Satya Babu.

← All specialty medicines, EU

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.